RaySearch Laboratories AB (publ)

Price Chart

Risk-Adjusted Performance

Also Listed On

RaySearch Laboratories AB (publ) (RAY-B) Price Performance

RaySearch Laboratories AB (publ) (RAY-B) trades on Nasdaq Stockholm in SEK. The company is classified in the Healthcare sector under the Health Information Services industry. The stock currently trades at SEK181.60, down 3.92% from the previous close.

Over the past year, RAY-B has traded between a low of SEK168.40 and a high of SEK365.50. The stock has lost 22.4% over this period. It is currently 50.3% below its 52-week high.

RaySearch Laboratories AB (publ) has a market capitalization of $6.52B, with a price-to-earnings ratio of 28.56 and a dividend yield of 2.10%.

About RaySearch Laboratories AB (publ)

RaySearch Laboratories AB (publ), a medical technology company, provides software solutions for cancer treatment worldwide. The company offers RayStation, a treatment planning system for cancer centers; RayCare, an oncology information system for clinics; RayIntelligence, cloud-based oncology analytics system that cancer centers can use to gather, structure and analyze data; and RayCommand, a treatment control system designed to link the treatment machine and the treatment planning and oncology information systems. It also provides µ-RayStation* (Micro-RayStation), a software platform for planning and evaluation in small animal irradiation research; RayPlan, a treatment planning system; DrugLog, which verifies the identity and concentration of compounded injectables before administered to a patient; RayMigrate, allows users to convert Pinnacle patient data to RayStation format and/or to DICOM format; and machine learning and liver ablation solutions. It has collaboration with Vision RT for integration of MapRT with RayStation treatment planning system. The company was founded in 2000 and is headquartered in Stockholm, Sweden.